Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
Submitted by
admin
on November 6, 2013 - 10:37am
Source:
Fierce Biotech
News Tags:
liver failure
Genentech
FDA
Curis
CUDC-427
breast cancer
Headline:
FDA puts a clamp on Curis cancer drug program after patient dies of liver failure
Do Not Allow Advertisers to Use My Personal information
